secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0001493152-23-005455
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed subsidiary terminates MSA with ResearchDx, saves $2.725M; settles EF Hutton lawsuit for $450k
--------------------------------------------------------------------------------

- Lucid Diagnostics terminated MSA with ResearchDx effective Feb 10, 2023; saved $2.725M vs $3.45M originally due.
- Termination payment of $725k satisfied by issuing 553,436 shares of Lucid Diagnostics common stock, no cash outlay.
- PAVmed settled EF Hutton/Benchmark litigation for $450k cash, full release of all claims related to 2020-2021 financings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223005455/0001493152-23-005455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223005455/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer